Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ge, Y.
Right arrow Articles by Grossman, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ge, Y.
Right arrow Articles by Grossman, R. I.
Related Collections
Right arrow All Imaging
Right arrow MRI
Right arrow MRS
Right arrow Multiple sclerosis
NEUROLOGY 2004;62:624-627
© 2004 American Academy of Neurology
Brief Communications

Neuronal cell injury precedes brain atrophy in multiple sclerosis

Y. Ge, MD, O. Gonen, PhD, M. Inglese, MD, J. S. Babb, PhD, C. E. Markowitz, MD and R. I. Grossman, MD

From the Department of Radiology (Drs. Ge, Gonen, Inglese, Babb, and Grossman), New York University School of Medicine, New York, NY; and Department of Neurology (Dr. Markowitz), University of Pennsylvania Medical Center, Philadelphia, PA.

Address correspondence and reprints request to Dr. Oded Gonen, Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY 10016; e-mail: oded.gonen{at}med.nyu.edu

Global brain atrophy estimated using MRI and whole brain N-acetylaspartate (WBNAA) concentration measured with proton MR spectroscopy were obtained in 42 patients with relapsing-remitting multiple sclerosis and 41 matched control subjects. Patients exhibited cross-sectional atrophy (0.5%; p = 0.033) and WBNAA decline (1.8%/y; p = 0.005) vs disease duration. The 3.6-fold rate disparity between the two processes suggests that neuronal/axonal dysfunction (N-acetylaspartate decline) precedes parenchyma loss, not its consequence (i.e., is an earlier, more sensitive specific metric of the ongoing disease activity).

Received April 24, 2003. Accepted in final form August 26, 2003.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
D.J. Rigotti, M. Inglese, and O. Gonen
Whole-Brain N-Acetylaspartate as a Surrogate Marker of Neuronal Damage in Diffuse Neurologic Disorders
AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1843 - 1849.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Rasmussen, Y. Wang, P. Kivisakk, R. T. Bronson, M. Meyer, J. Imitola, and S. J. Khoury
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis
Brain, November 1, 2007; 130(11): 2816 - 2829.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Pulizzi, M. Rovaris, E. Judica, M. P. Sormani, V. Martinelli, G. Comi, and M. Filippi
Determinants of Disability in Multiple Sclerosis at Various Disease Stages: A Multiparametric Magnetic Resonance Study
Arch Neurol, August 1, 2007; 64(8): 1163 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. L. Arnold
Evidence for neuroprotection and remyelination using imaging techniques
Neurology, May 29, 2007; 68(22_suppl_3): S83 - S90.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
Y. Ge
Multiple Sclerosis: The Role of MR Imaging
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al.
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Arch Neurol, April 1, 2006; 63(4): 614 - 619.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
J. Imitola, T. Chitnis, and S. J. Khoury
Insights Into the Molecular Pathogenesis of Progression in Multiple Sclerosis: Potential Implications for Future Therapies
Arch Neurol, January 1, 2006; 63(1): 25 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Rovaris, A. Gallo, A. Falini, B. Benedetti, P. Rossi, M. Comola, G. Scotti, G. Comi, and M. Filippi
Axonal Injury and Overall Tissue Loss Are Not Related in Primary Progressive Multiple Sclerosis
Arch Neurol, June 1, 2005; 62(6): 898 - 902.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. A. Kamholz, J. Y. Garbern, O. Gonen, Y. Ge, M. Inglese, and R. I. Grossman
Neuronal cell injury precedes brain atrophy in multiple sclerosis
Neurology, January 11, 2005; 64(1): 176 - 176.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Neuronal cell injury precedes brain atrophy in multiple sclerosis
John A. Kamholz, et al.
Neurology Online, 15 Jul 2004 [Full text]
Reply to Kamholz et al
Oded Gonen, MD
Neurology Online, 15 Jul 2004 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.